ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.898,80
1,23%
S&P 500
5.352,96
-0,02%
US Dollar vs BRL
5,2586
0,00%
Bitcoin
70.690,19
-0,10%
Brent Oil
79,80
-0,10%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Foamix Pharmaceuticals Ltd (FOMX)

  7. Foamix Pharmaceuticals Ltd (FOMX) Notícias

FOMX

Foamix Pharmaceuticals (FOMX)

Foamix Pharmaceuticals Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:FOMX
DataHoraFonteTítuloCódigoCompanhia
23/03/202007:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
19/03/202016:10Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202017:34Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202017:31Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202010:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/03/202008:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/03/202008:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
09/03/202010:27Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:FOMXFoamix Pharmaceuticals Ltd
03/03/202019:02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
14/02/202019:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
28/01/202018:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
07/01/202018:51Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/11/201919:09PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd.NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/11/201908:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
19/08/201917:37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
15/08/201918:11Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
06/08/201918:12Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/04/201917:25Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/201907:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
08/03/201910:44Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
01/03/201919:04Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
14/09/201817:22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
02/04/201817:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
01/03/201818:31Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
28/11/201719:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
14/09/201708:00PR Newswire (US)OWC Pharma Issues Chairman's Letter to ShareholdersNASDAQ:FOMXFoamix Pharmaceuticals Ltd
24/02/201718:07Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
21/02/201718:09Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/09/201617:02Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
09/03/201621:46GlobeNewswire Inc.Foamix to Present Corporate Overview at the 36th Annual Cowen & Company Healthcare ConferenceNASDAQ:FOMXFoamix Pharmaceuticals Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:FOMX

Seu Histórico Recente

BIT
P1XXR9
NLBNPIT1XXR9 20240621 240
LSE
TUN
Tungsten West
TSXV
PVIS
Parvis Invest
LSE
43HD
Municplty 1.35%
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados